. . .

Andrea Marzi1, Peter Halfmann2, Lindsay Hill-Batorski2

  • 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.

Science (New York, N.Y.)
|March 28, 2015
PubMed
概括

一种新型埃博拉病毒 (EBOV) 候选疫苗,EBOVΔVP30,在非人类灵长类动物中证明了对致命的EBOV感染的保护. 这种全EBOV疫苗具有所有病毒成分,可能增强免疫反应.